PriceTargets.com logo

USANA Health Sciences - USNA Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $35.00
  • Forecasted Upside: -11.44%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$39.52 As of 11/20/2024 01:00 AM ET
▲ +0.48 (1.23%)

This chart shows the closing price for USNA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New USANA Health Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for USNA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for USNA

Analyst Price Target is $35.00
▼ -11.44% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for USANA Health Sciences in the last 3 months. The average price target is $35.00, with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a -11.44% upside from the last price of $39.52.

This chart shows the closing price for USNA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 contributing investment analysts is to hold stock in USANA Health Sciences. This rating has held steady since May 2024, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/23/2024DA DavidsonLower TargetNeutral ➝ Neutral$38.00 ➝ $35.00
7/25/2024DA DavidsonLower TargetNeutral ➝ Neutral$46.00 ➝ $38.00
5/7/2024DA DavidsonLower TargetNeutral ➝ Neutral$48.00 ➝ $46.00
2/22/2024DA DavidsonLower TargetNeutral ➝ Neutral$53.00 ➝ $48.00
10/25/2023DA DavidsonLower TargetNeutral ➝ Neutral$62.00 ➝ $53.00
7/27/2023DA DavidsonBoost Target$56.00 ➝ $62.00
6/23/2023SidotiInitiated CoverageBuy
4/26/2023DA DavidsonBoost Target$52.50 ➝ $56.00
2/13/2023DA DavidsonBoost TargetNeutral$49.00 ➝ $52.50
10/27/2022DA DavidsonLower TargetNeutral$57.00 ➝ $49.00
7/27/2022DA DavidsonLower TargetOutperform$57.00
7/12/2022DA DavidsonLower TargetNeutral$76.00 ➝ $58.00
7/7/2022Jefferies Financial GroupDowngradeHold ➝ Underperform$78.00 ➝ $53.00
4/27/2022DA DavidsonLower Target$86.00 ➝ $76.00
4/13/2022DA DavidsonInitiated CoverageNeutral$86.00
10/8/2021Tigress FinancialReiterated RatingBuy$122.00
2/10/2021Roth CapitalBoost TargetBuy$107.00 ➝ $126.00
12/17/2020Roth CapitalInitiated CoverageBuy$107.00
5/12/2020Tigress FinancialReiterated RatingBuy
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.45 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024
  • 17 very positive mentions
  • 22 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/24/2024
  • 6 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/23/2024
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/23/2024
  • 9 very positive mentions
  • 12 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
8/22/2024
  • 5 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 4 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 8 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2024

Current Sentiment

  • 8 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

USANA Health Sciences logo
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $39.52
Low: $38.85
High: $39.53

50 Day Range

MA: $37.78
Low: $34.50
High: $41.29

52 Week Range

Now: $39.52
Low: $34.15
High: $54.81

Volume

66,309 shs

Average Volume

81,100 shs

Market Capitalization

$753.25 million

P/E Ratio

13.96

Dividend Yield

N/A

Beta

0.89

Frequently Asked Questions

What sell-side analysts currently cover shares of USANA Health Sciences?

The following Wall Street research analysts have issued research reports on USANA Health Sciences in the last twelve months: DA Davidson, and StockNews.com.
View the latest analyst ratings for USNA.

What is the current price target for USANA Health Sciences?

0 Wall Street analysts have set twelve-month price targets for USANA Health Sciences in the last year. Their average twelve-month price target is $35.00, suggesting a possible downside of 11.4%. DA Davidson has the highest price target set, predicting USNA will reach $35.00 in the next twelve months. DA Davidson has the lowest price target set, forecasting a price of $35.00 for USANA Health Sciences in the next year.
View the latest price targets for USNA.

What is the current consensus analyst rating for USANA Health Sciences?

USANA Health Sciences currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in USNA, but not buy more shares or sell existing shares.
View the latest ratings for USNA.

What other companies compete with USANA Health Sciences?

Other companies that are similar to USANA Health Sciences include Herbalife, Nu Skin Enterprises, Nature's Sunshine Products, Medifast and Veru. Learn More about companies similar to USANA Health Sciences.

How do I contact USANA Health Sciences' investor relations team?

USANA Health Sciences' physical mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company's listed phone number is (801) 954-7100 and its investor relations email address is [email protected]. The official website for USANA Health Sciences is www.usana.com. Learn More about contacing USANA Health Sciences investor relations.